Leo Wealth LLC purchased a new stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 4,635 shares of the company’s stock, valued at approximately $673,000.
Other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $27,862,105,000. Bank of America Corp DE purchased a new position in Procter & Gamble during the second quarter valued at approximately $3,850,628,000. Bank of New York Mellon Corp purchased a new position in Procter & Gamble during the second quarter valued at approximately $2,281,505,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Procter & Gamble in the second quarter worth approximately $1,480,650,000. Finally, Corient Private Wealth LP bought a new position in shares of Procter & Gamble in the second quarter worth approximately $335,908,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Down 0.7%
PG opened at $159.96 on Tuesday. The firm has a 50-day simple moving average of $148.38 and a two-hundred day simple moving average of $148.47. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $167.25. The company has a market capitalization of $370.75 billion, a PE ratio of 23.34, a price-to-earnings-growth ratio of 4.00 and a beta of 0.39. The company has a quick ratio of 0.53, a current ratio of 0.72 and a debt-to-equity ratio of 0.40.
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The company’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.99 EPS. Analysts forecast that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be given a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio is currently 65.51%.
Analyst Ratings Changes
Several brokerages have recently commented on PG. Morgan Stanley raised their price objective on shares of Procter & Gamble from $166.00 to $185.00 and gave the company an “overweight” rating in a research report on Friday. Bank of America dropped their target price on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a report on Friday, July 10th. Wells Fargo & Company increased their price target on Procter & Gamble from $164.00 to $180.00 and gave the stock an “overweight” rating in a research note on Friday. Freedom Broker raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 price target on the stock in a report on Friday. Finally, BNP Paribas Exane boosted their price objective on Procter & Gamble from $177.00 to $189.00 and gave the company an “outperform” rating in a research report on Friday. Fifteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $170.57.
Get Our Latest Research Report on PG
Trending Headlines about Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Exchange-traded funds purchased approximately $82.8 million of PG stock on October 22, indicating institutional demand and potentially providing support for the shares. ETFs Bought $82.8 Million of Procter & Gamble
- Positive Sentiment: Several analysts remain constructive: JPMorgan raised its price target, while TD Cowen, BNP Paribas Exane and Citigroup reportedly forecast further appreciation. Freedom Broker also upgraded PG to Buy. JPMorgan Price Target Increase TD Cowen Forecast
- Positive Sentiment: Investment commentary highlights PG’s strong household-product market shares and appeal as a high-yield, defensive dividend stock—factors that may attract income-oriented investors. High-Yield Dividend Stock Comparison
- Neutral Sentiment: Articles comparing PG with Colgate-Palmolive and discussing TIPS, Treasury bills and dividend stocks reinforce PG’s defensive and income-investment appeal, but provide limited new company-specific information. PG Versus CL
- Negative Sentiment: Higher oil prices could raise manufacturing, packaging, transportation and other costs. Unless offset by pricing or productivity gains, this would pressure PG’s margins and earnings outlook. Impact of Higher Oil Prices
- Negative Sentiment: Insiders reported notable selling: Shailesh Jejurikar sold 35,000 shares worth about $5.7 million, while other executives sold shares as well. These transactions are not necessarily bearish, but the reductions in ownership can create a modest sentiment overhang. SEC Insider Filing
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO Paul Gama sold 4,331 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $161.27, for a total value of $698,460.37. Following the completion of the sale, the chief executive officer owned 46,793 shares of the company’s stock, valued at $7,546,307.11. This trade represents a 8.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Andre Schulten sold 3,914 shares of the company’s stock in a transaction on Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $568,860.76. Following the completion of the transaction, the chief financial officer directly owned 65,618 shares in the company, valued at $9,536,920.12. This trade represents a 5.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 58,647 shares of company stock worth $9,268,508 in the last quarter. Company insiders own 0.23% of the company’s stock.
About Procter & Gamble
Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.
The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.
See Also
- Five stocks we like better than Procter & Gamble
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
